New CAR T cell therapy approach minimizes severe side effects
Six CAR T cell therapies have received FDA approval, and several more are in the pipeline. However, these therapies carry serious and potentially fatal side effects, namely cytokine release syndrome (CRS) and neurotoxicity. These drawbacks manifest themselves in a range of symptoms, from high fever and vomiting to multivisceral failure and patient death, posing significant […]
